The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 11-12, 2007, Pages 1192-1198

  Nagai, Ryoji ^a   Mera, Katsumi ^a   Nakajou, Keisuke ^a   Fujiwara, Yukio ^a   Iwao, Yasunori ^a   Imai, Hiroki ^b   Murata, Toshinori ^b   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products (AGEs); Atherosclerosis; Diabetes; Macrophage; N (carboxymethyl)lysine (CML); Scavenger receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CD36 ANTIGEN; INDIUM 111; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCAVENGER RECEPTOR BI; SERUM ALBUMIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIGAND BINDING; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS;

ALDEHYDES; ANIMALS; CATTLE; CHO CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRICETULUS; CRYSTALLINS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIGANDS; LYSINE; MACROPHAGES; MICE; RECEPTORS, SCAVENGER; SERUM ALBUMIN, BOVINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TISSUE DISTRIBUTION;

BOVINAE; CRICETULUS GRISEUS; MUS;

EID: 37049008850     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.09.001     Document Type: Article

References (29)

1. Higashi T., Sano H., Saishoji T., Ikeda K., Jinnouchi Y., Kanzaki T., Morisaki N., Rauvala H., Shichiri M., and Horiuchi S. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes 46 (1997) 463-472
2. Jinnouchi Y., Sano H., Nagai R., Hakamata H., Kodama T., Suzuki H., Yoshida M., Ueda S., and Horiuchi S. Glycolaldehyde-modified low density lipoprotein leads macrophages to foam cells via the macrophage scavenger receptor. J. Biochem. (Tokyo) 123 (1998) 1208-1217
3. Nagai R., Matsumoto K., Ling X., Suzuki H., Araki T., and Horiuchi S. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49 (2000) 1714-1723
4. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Kodama T., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386 (1997) 292-296
5. Ohgami N., Nagai R., Ikemoto M., Arai H., Kuniyasu A., Horiuchi S., and Nakayama H. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J. Biol. Chem. 276 (2001) 3195-3202
6. Ohgami N., Nagai R., Miyazaki A., Ikemoto M., Arai H., Horiuchi S., and Nakayama H. Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products. J. Biol. Chem. 276 (2001) 13348-13355
7. Jono T., Miyazaki A., Nagai R., Sawamura T., Kitamura T., and Horiuchi S. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett. 511 (2002) 170-174
8. Schmidt A.M., Vianna M., Gerlach M., Brett J., Ryan J., Kao J., Esposito C., Hegarty H., Hurley W., Clauss M., et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267 (1992) 14987-14997
9. Schmidt A.M., Hori O., Chen J.X., Li J.F., Crandall J., Zhang J., Cao R., Yan S.D., Brett J., and Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96 (1995) 1395-1403
10. Ichikawa K., Yoshinari M., Iwase M., Wakisaka M., Doi Y., Iino K., Yamamoto M., and Fujishima M. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis 136 (1998) 281-287
11. Vlassara H., Fuh H., Makita Z., Krungkrai S., Cerami A., and Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 12043-12047
12. Cai W., He J.C., Zhu L., Lu C., and Vlassara H. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13801-13806
13. Takeuchi M., and Yamagishi S. Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo. Med. Hypotheses 63 (2004) 453-455
14. Nagai R., Unno Y., Hayashi M.C., Masuda S., Hayase F., Kinae N., and Horiuchi S. Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 51 (2002) 2833-2839
15. Thornalley P.J., Argirova M., Ahmed N., Mann V.M., Argirov O., and Dawnay A. Mass spectrometric monitoring of albumin in uremia. Kidney Int. 58 (2000) 2228-2234
16. Koito W., Araki T., Horiuchi S., and Nagai R. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody. J. Biochem. (Tokyo) 136 (2004) 831-837
17. Fukuhara-Takaki K., Sakai M., Sakamoto Y., Takeya M., and Horiuchi S. Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes. J. Biol. Chem. 280 (2005) 3355-3364
18. Hnatowich D.J., Latne W.W., and Childs R.L. The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Isot. 33 (1982) 327-332
19. Yamaoka K., Tanigawara Y., Nakagawa T., and Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobio-Dyn. 4 (1981) 879-885
20. Dunn J.A., Patrick J.S., Thorpe S.R., and Baynes J.W. Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins. Biochemistry 28 (1989) 9464-9468
21. Horiuchi S., Sakamoto Y., and Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 25 (2003) 283-292
22. Smedsrod B., Melkko J., Araki N., Sano H., and Horiuchi S. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem. J. 322 Pt 2 (1997) 567-573
23. Matsumoto K., Sano H., Nagai R., Suzuki H., Kodama T., Yoshida M., Ueda S., Smedsrod B., and Horiuchi S. Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A. Biochem. J. 352 Pt 1 (2000) 233-240
24. Fu M.X., Requena J.R., Jenkins A.J., Lyons T.J., Baynes J.W., and Thorpe S.R. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271 (1996) 9982-9986
25. Nagai R., Hayashi C.M., Xia L., Takeya M., and Horiuchi S. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J. Biol. Chem. 277 (2002) 48905-48912
26. Hammes H.P., Du X., Edelstein D., Taguchi T., Matsumura T., Ju Q., Lin J., Bierhaus A., Nawroth P., Hannak D., Neumaier M., Bergfeld R., Giardino I., and Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med. 9 (2003) 294-299
27. Abordo E.A., Westwood M.E., and Thornalley P.J. Synthesis and secretion of macrophage colony stimulating factor by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol. Lett. 53 (1996) 7-13
28. Abordo E.A., and Thornalley P.J. Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol. Lett. 58 (1997) 139-147
29. Xu B., Ji Y., Yao K., Cao Y.X., and Ferro A. Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes. Clin. Sci. (Lond) 109 (2005) 439-446